Pilot or pivotal ? [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2018-06-27 22:13 (1129 d 00:57 ago) – Posting: # 18982
Views: 10,106

Hi Ohlbe,

» But then, isn't this whole discussion on alpha correction purely hypothetical too ?

As I see it, it is a mild case of testing into compliance if we don't correct alpha:
If T1 and T2 are both borderline bad (like GMR=0.8) then we will have increased prob >5% type I error) of approving one of them, i.e. approving an unapprovable product.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,594 posts in 4,515 threads, 1,532 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Friday 23:10 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5